Search results
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 9 months agoAmneal Pharmaceuticals, Inc. (NYSE:AMRX) Q2 2023 Earnings Call Transcript August 4, 2023 Amneal...
Bausch (BHC) Down on Tentative Approval to Xifaxan ANDA
Zacks via Yahoo Finance· 11 months agoShares of Bausch Health Companies Inc. BHC were down 8.69% on Jun 6 after the FDA granted tentative...
Bausch (BHC) Starts Litigation Against Amneal for Xifaxan
Zacks via Yahoo Finance· 2 weeks agoBausch Health BHC, along with its gastroenterology business, Salix Pharmaceuticals, Inc., announced...
Elite Pharmaceuticals Inc Reports Significant Revenue and Operating Profit Growth in Q3 Fiscal 2024
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Increased by 68% to $15.5 million in Q3 FY2024 compared to the same period last year....
Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Generic Competition in Q3 2023
GuruFocus.com via Yahoo Finance· 5 months agoVanda Pharmaceuticals Inc (NASDAQ:VNDA) reports a 41% decrease in total net product sales in Q3 2023...
Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance
GuruFocus.com via Yahoo Finance· 2 months agoNet Revenues: $178.1 million for Q4 2023, a 32% increase year-over-year. GAAP Net Income: $36.2...
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
Benzinga via Yahoo Finance· 1 year agoCatalyst Pharmaceuticals Inc (NASDAQ: CPRX) has received a Notice Letter stating that Teva...
Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision
Zacks via Yahoo Finance· 2 years agoBausch Health Companies Inc. BHC has announced that it will appeal to the U.S. Court of Appeals for...
Bausch Health (BHC) Q3 Earnings & Sales Beat, '23 View Updated
Zacks via Yahoo Finance· 6 months agoBausch Health Companies Inc.'s BHC third-quarter results were better than expected. The company’s...
Intercept (ICPT) Settles Litigation With Dr. Reddy's for Ocaliva
Zacks via Yahoo Finance· 2 years agoShares of Intercept Pharmaceuticals, Inc. ICPT were up 3.65% on Aug 17 after the company announced a...